AU2008211807B2 - Method for producing novel IgE based reagents - Google Patents

Method for producing novel IgE based reagents Download PDF

Info

Publication number
AU2008211807B2
AU2008211807B2 AU2008211807A AU2008211807A AU2008211807B2 AU 2008211807 B2 AU2008211807 B2 AU 2008211807B2 AU 2008211807 A AU2008211807 A AU 2008211807A AU 2008211807 A AU2008211807 A AU 2008211807A AU 2008211807 B2 AU2008211807 B2 AU 2008211807B2
Authority
AU
Australia
Prior art keywords
binding
protein
ige
ligand
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008211807A
Other languages
English (en)
Other versions
AU2008211807A1 (en
Inventor
Sirpa Jylha
Marja-Leena Laukkanen
Merja Niemi
Juha Rouvinen
Hans Soderlund
Kristiina Takkinen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VTT Technical Research Centre of Finland Ltd
Original Assignee
VTT Technical Research Centre of Finland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20075059A external-priority patent/FI20075059A0/fi
Priority claimed from FI20075707A external-priority patent/FI20075707A0/fi
Application filed by VTT Technical Research Centre of Finland Ltd filed Critical VTT Technical Research Centre of Finland Ltd
Publication of AU2008211807A1 publication Critical patent/AU2008211807A1/en
Application granted granted Critical
Publication of AU2008211807B2 publication Critical patent/AU2008211807B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2008211807A 2007-01-29 2008-01-29 Method for producing novel IgE based reagents Ceased AU2008211807B2 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FI20075059 2007-01-29
FI20075059A FI20075059A0 (fi) 2007-01-29 2007-01-29 Allergeeniä sitovat monoklonaaliset IgE-vasta-aineet ja hypoallergeenit:tyypin l lgE:n ja allergeenin immunokompleksivuorovaikutus
US88786207P 2007-02-02 2007-02-02
US60/887,862 2007-02-02
US97788107P 2007-10-05 2007-10-05
US60/977,881 2007-10-05
FI20075707 2007-10-05
FI20075707A FI20075707A0 (fi) 2007-10-05 2007-10-05 Menetelmä uusien IgE-pohjaisten reagenssien valmistamiseksi
PCT/FI2008/050027 WO2008092993A1 (en) 2007-01-29 2008-01-29 Method for producing novel ige based reagents

Publications (2)

Publication Number Publication Date
AU2008211807A1 AU2008211807A1 (en) 2008-08-07
AU2008211807B2 true AU2008211807B2 (en) 2013-09-19

Family

ID=39673692

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008211807A Ceased AU2008211807B2 (en) 2007-01-29 2008-01-29 Method for producing novel IgE based reagents

Country Status (7)

Country Link
US (1) US20100311604A1 (https=)
EP (1) EP2115139B8 (https=)
JP (1) JP2010516747A (https=)
AU (1) AU2008211807B2 (https=)
CA (1) CA2676843A1 (https=)
NZ (1) NZ577858A (https=)
WO (1) WO2008092993A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011156734A2 (en) 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
JP5755326B2 (ja) * 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
US9719129B2 (en) 2011-06-10 2017-08-01 Hitachi Chemical Co., Ltd. Methods for isolating vesicles from biological fluids
WO2014003008A1 (ja) 2012-06-28 2014-01-03 国立大学法人広島大学 ヒト汗中に含まれる新規ヒスタミン遊離物質
WO2014027626A1 (ja) 2012-08-17 2014-02-20 国立大学法人広島大学 汗アレルギー抗原蛋白質に結合するモノクローナルIgE抗体
JP6297676B2 (ja) 2013-05-06 2018-03-20 日立化成株式会社 標的分子を捕捉するためのデバイス及び方法
EP2820947A1 (en) * 2013-07-05 2015-01-07 B Cell Design Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
US10370719B2 (en) 2014-11-12 2019-08-06 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
WO2017152088A1 (en) 2016-03-04 2017-09-08 JN Biosciences, LLC Antibodies to tigit
CN110234352A (zh) * 2017-01-31 2019-09-13 Msm蛋白质技术公司 抗cxcr4抗体
BR112022024221A2 (pt) 2020-06-02 2022-12-20 Arcus Biosciences Inc Anticorpos para tigit
CN119626432B (zh) * 2025-02-17 2025-05-27 杭州艾替捷英科技有限公司 针对宠物过敏源检测结果大数据的云架构聚类管理方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
US6063621A (en) * 1992-10-27 2000-05-16 Queen's University At Kingston Antibodies to a multidrug resistance protein
ZA966075B (en) * 1995-07-27 1998-01-19 Genentech Inc Protein formulation.
US6299875B1 (en) * 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
FI112501B (fi) * 2001-05-18 2003-12-15 Valtion Teknillinen Heveiiniä sitovat monoklonaaliset vasta-aineet
US7438907B2 (en) * 2002-11-15 2008-10-21 Genmab A/S Human monoclonal antibodies against CD25
JP2005024245A (ja) * 2003-03-25 2005-01-27 Rikogaku Shinkokai Ａｂｃタンパク質と相互作用する物質のスクリーニング方法
WO2005051299A2 (en) * 2003-11-19 2005-06-09 Dyax Corp. Metalloproteinase-binding proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
De Genst, E. et al., PNAS, 2006, vol. 103, no. 12, pp4586-4591. *

Also Published As

Publication number Publication date
US20100311604A1 (en) 2010-12-09
NZ577858A (en) 2012-02-24
EP2115139A1 (en) 2009-11-11
CA2676843A1 (en) 2008-08-07
EP2115139B1 (en) 2015-01-28
EP2115139A4 (en) 2011-03-23
JP2010516747A (ja) 2010-05-20
WO2008092993A1 (en) 2008-08-07
AU2008211807A1 (en) 2008-08-07
EP2115139B8 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
AU2008211807B2 (en) Method for producing novel IgE based reagents
Muyldermans A guide to: generation and design of nanobodies
Könning et al. Camelid and shark single domain antibodies: structural features and therapeutic potential
Huston et al. Engineered antibodies take center stage
Peng et al. Mining naive rabbit antibody repertoires by phage display for monoclonal antibodies of therapeutic utility
JP2010516747A5 (https=)
US8241858B2 (en) Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
EP1918302A2 (en) Methods for the identification and the isolation of epitope specific antibodies
Azriel-Rosenfeld et al. A human synthetic combinatorial library of arrayable single-chain antibodies based on shuffling in vivo formed CDRs into general framework regions
Tillib “Camel nanoantibody” is an efficient tool for research, diagnostics and therapy
Ferrari et al. A novel nanobody scaffold optimized for bacterial expression and suitable for the construction of ribosome display libraries
CN109336973B (zh) 抗转铁蛋白抗体及其用途
CN110642947B (zh) 抗人cd147的单克隆抗体、表达载体、细胞株及其应用
JP2001515921A (ja) テストステロンと結合するモノクローナル抗体
US20240287501A1 (en) Means and Methods for Selection of Specific Binders
Padoa et al. Engineered antibodies: A new tool for use in diabetes research
Alvarenga et al. Recombinant antibodies: trends for standardized immunological probes and drugs
US20050118161A1 (en) Hevein-binding monoclonal antibodies
KR102053749B1 (ko) 임질균 특이적 항체 및 이의 용도
Kramer et al. Antibodies for biosensors
CN113999306B (zh) 一种获得识别空间构象表位抗体的方法
US20260118366A1 (en) Method for selecting or screening antibodies and antigens from an antibody library
Hammond et al. Isolation of antibodies which neutralise the activity of early pregnancy factor
DE PONT Max Planck Institute for Biophysics
CN117836308A (zh) 用于选择特异性结合剂的手段和方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired